<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.66224/phypha</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1394</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2015</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>19</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Carbon nanotubes prolong the regulatory action of nerve growth factor on the endocannabinoid signaling </title>
	<subject_fa>Nervous system (others)</subject_fa>
	<subject>Others</subject>
	<content_type_fa>Experimental research article</content_type_fa>
	<content_type>Experimental research article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p dir=&quot;ltr&quot; style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size: 11px;&quot;&gt;Introduction: &lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;Carbon nanotubes (CNTs) have shown enormous potential in neuroscience. Nerve growth factor (NGF)-CNTs complex promotes the neuronal growth, however, the underlying mechanism(s) have remained elusive. Based on the interplay between NGF and the endocannabinoid system, involvement of the neuroprotective endocannabinoid, 2-arachidonoyl glycerol (2-AG), was investigated in the mechanism of action of NGF. &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 11px;&quot;&gt;Materials and Methods: &lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;Multi-walled CNTs (MWCNTs)-NGF complex was prepared using amino-functionalized COOH-MWCNTs. MWCNTs were characterized by Fourier transform infrared (FTIR) spectroscopy and scanning electron microscopy (SEM). &lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;In vitro &lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;cytotoxicity was evaluated by MTT assay. Following three times daily intracerebroventricular injections of NGF solution (2, 5, and 10 &amp;mug), and 5, 10, and 20 &amp;mug of acid- or amine-modified MWCNTs, or MWCNTs-NGF complex for either one or 7 days, 2-AG contents were quantified in the frontal cortex and hippocampus of rats by isotope-dilution liquid chromatography/mass spectrometry. &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 11px;&quot;&gt;Results: &lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;FTIR confirmed the amino-functionalization of COOH-MWCNTs and NGF immobilization on the aminated MWCNTs. Aminated MWCNTs and MWCNTs-NGF complex showed less cytotoxicity than COOH-MWCNTs (&lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.05, &lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.01, and &lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.01). Chronic, but not acute, administration of MWCNTs-NGF complex and NGF solution at the highest dose tested led to the elevation of 2-AG at 1 h from the last injection (&lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.01 and &lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.001). 2-AG enhancement induced by MWCNTs-NGF complex lasted for up to 5 and 12 h post-injection (&lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.01 and &lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;0.001). 2-AG contents remained at the baseline level in the sham and groups receiving vehicle, acid- or amine-modified MWCNTs (&lt;/font&gt;&lt;/font&gt;&lt;i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;P&lt;/font&gt;&lt;/font&gt;&lt;/i&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;&gt;0.05). &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 11px;&quot;&gt;Conclusion: &lt;font face=&quot;Arial,Arial&quot;&gt;&lt;font face=&quot;Arial,Arial&quot;&gt;Functionalized MWCNTs-NGF complex induces a long-lasting increase of brain 2-AG content indicating the efficiency of this nanostructure to provide a sustained concentration of NGF. Implication of 2-AG in the mechanism of action of NGF might be of great therapeutic significance in the neurological disorders. &lt;/font&gt;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Carbon nanotubes, Nerve growth factor, Endocannabinoid signaling</keyword>
	<start_page>167</start_page>
	<end_page>176</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-10-858-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Parichehr</first_name>
	<middle_name></middle_name>
	<last_name>Hassanzadeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hassanzadehparichehr4@gmail.com</email>
	<code>3200319475328460015865</code>
	<orcid>3200319475328460015865</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Elham</first_name>
	<middle_name></middle_name>
	<last_name>Arbabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>arbabiavalelham@gmail.com</email>
	<code>3200319475328460015866</code>
	<orcid>3200319475328460015866</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Research Centre for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Rostami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>frostamii@yahoo.com</email>
	<code>3200319475328460015867</code>
	<orcid>3200319475328460015867</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Research Centre for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fatemeh</first_name>
	<middle_name></middle_name>
	<last_name>Atyabi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460015868</code>
	<orcid>3200319475328460015868</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rassoul</first_name>
	<middle_name></middle_name>
	<last_name>Dinarvand</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460015869</code>
	<orcid>3200319475328460015869</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
